TY - JOUR
T1 - Early growth response 1 and NF-ATc1 act in concert to promote thymocyte development beyond the β-selection checkpoint
AU - Koltsova, Ekaterina K.
AU - Ciofani, Maria
AU - Benezra, Robert
AU - Miyazaki, Toru
AU - Clipstone, Neil
AU - Zúñiga-Pflücker, Juan Carlos
AU - Wiest, David L.
PY - 2007/10/1
Y1 - 2007/10/1
N2 - Development of immature T cell precursors beyond the β-selection checkpoint is regulated by signals transduced by the pre-TCR complex. The pre-TCR-induced differentiation program is orchestrated by a network of transcription factors that serve to integrate this signaling information. Among these transcription factors are those of the early growth response (Egr) and NF-AT families. In this study, we demonstrate that Egr1 and NF-ATc1 act together to promote development of T cell precursors beyond the β-selection checkpoint to the CD8 immature single-positive and CD4+CD8 + double-positive stages. Moreover, we find that Egr1 and NF-AT cooperatively induce the expression of inhibitor of DNA binding 3 (Id3), a regulatory factor known to play an important role in positive selection of thymocytes, but not previously demonstrated to be required for β-selection. Importantly, we show in this study that Id3 deficiency abrogates the ability of ectopically expressed Egr1 to promote traversal of the β-selection checkpoint. Id3 is presumably essential for traversal of the β-selection checkpoint in this context because of the inability of other inhibitor of DNA binding family members to compensate, since transgenic Egr1 does not induce expression of inhibitor of DNA binding 1 (Id1) or 2 (Id2). Taken together, these data demonstrate that Id3 is a cooperatively induced target that is important for Egr-mediated promotion of development beyond the β-selection checkpoint. Moreover, these data indicate that the ERK and calcium signaling pathways may converge during β-selection through the concerted action of Egr1 and NF-ATc1, respectively.
AB - Development of immature T cell precursors beyond the β-selection checkpoint is regulated by signals transduced by the pre-TCR complex. The pre-TCR-induced differentiation program is orchestrated by a network of transcription factors that serve to integrate this signaling information. Among these transcription factors are those of the early growth response (Egr) and NF-AT families. In this study, we demonstrate that Egr1 and NF-ATc1 act together to promote development of T cell precursors beyond the β-selection checkpoint to the CD8 immature single-positive and CD4+CD8 + double-positive stages. Moreover, we find that Egr1 and NF-AT cooperatively induce the expression of inhibitor of DNA binding 3 (Id3), a regulatory factor known to play an important role in positive selection of thymocytes, but not previously demonstrated to be required for β-selection. Importantly, we show in this study that Id3 deficiency abrogates the ability of ectopically expressed Egr1 to promote traversal of the β-selection checkpoint. Id3 is presumably essential for traversal of the β-selection checkpoint in this context because of the inability of other inhibitor of DNA binding family members to compensate, since transgenic Egr1 does not induce expression of inhibitor of DNA binding 1 (Id1) or 2 (Id2). Taken together, these data demonstrate that Id3 is a cooperatively induced target that is important for Egr-mediated promotion of development beyond the β-selection checkpoint. Moreover, these data indicate that the ERK and calcium signaling pathways may converge during β-selection through the concerted action of Egr1 and NF-ATc1, respectively.
KW - Animals
KW - Cell Differentiation/immunology
KW - Cell Line
KW - Early Growth Response Protein 1/genetics
KW - Gene Expression Regulation
KW - Humans
KW - Inhibitor of Differentiation Proteins/metabolism
KW - Mice
KW - Mice, Transgenic
KW - NFATC Transcription Factors/metabolism
KW - Signal Transduction
KW - T-Lymphocytes/cytology
KW - Thymus Gland/cytology
UR - http://www.scopus.com/inward/record.url?scp=59849096559&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000249752100047&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.4049/jimmunol.179.7.4694
DO - 10.4049/jimmunol.179.7.4694
M3 - Article
C2 - 17878368
SN - 0022-1767
VL - 179
SP - 4694
EP - 4703
JO - Journal of Immunology
JF - Journal of Immunology
IS - 7
ER -